Cargando…
Gene Therapy for Primary Immunodeficiency
Over the past 3 decades, there has been significant progress in refining gene therapy technologies and procedures. Transduction of hematopoietic stem cells ex vivo using lentiviral vectors can now create a highly effective therapeutic product, capable of reconstituting many different immune system d...
Autores principales: | Houghton, Benjamin C., Booth, Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773329/ https://www.ncbi.nlm.nih.gov/pubmed/33403354 http://dx.doi.org/10.1097/HS9.0000000000000509 |
Ejemplares similares
-
Advances of gene therapy for primary
immunodeficiencies
por: Candotti, Fabio
Publicado: (2016) -
Tailored therapies for primary immunodeficiencies
por: Cinicola, Bianca, et al.
Publicado: (2021) -
Gene therapy and genome editing for primary immunodeficiency diseases
por: Zhang, Zhi-Yong, et al.
Publicado: (2019) -
Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing
por: Eguizabal, C., et al.
Publicado: (2020) -
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
por: Rai, Rajeev, et al.
Publicado: (2021)